Caveolae--an alternative endocytotic pathway for targeted drug delivery.
about
Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albuminEngineering surfaces for substrate-mediated gene delivery using recombinant proteins.Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancerPhase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors.Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV preventionEndocytic mechanisms for targeted drug deliveryGene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density.Targeting cancer with 'smart bombs': equipping plant virus nanoparticles for a 'seek and destroy' mission.Nanopreparations for organelle-specific delivery in cancerDesign of chitosan-based nanoformulations for efficient intracellular release of active compounds.Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines.Endocytosis in gene therapy with non-viral vectors.Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.The involvement of microtubules and actin filaments in the intracellular transport of non-viral gene delivery system.Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice.Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells.CRM197-induced blood-brain barrier permeability increase is mediated by upregulation of caveolin-1 protein.Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model.
P2860
Q30997634-13A10EB8-834D-4A3B-82E5-9FC7B99B869FQ33506146-18BF0119-E6F1-4F7F-9EA9-E91BA43947E0Q33881254-A8B3BE3C-34FE-4D1D-A86B-C75BD95B701AQ33923397-36376906-C0DF-44C4-8C94-90BDE38094C8Q34784522-33D58FFF-B55A-47E2-9C00-427949B50716Q36894849-F9036CC8-EB73-4B94-B166-497690FAA0DAQ37137886-69BD6A19-0F66-40DA-954E-A14500087FEDQ37538780-B392E646-B92E-46D4-A84B-46E5CF3FAC27Q38165639-C08D9839-1162-43F1-9641-EB2EB6198DEBQ38211728-E870D820-A09E-478F-BB4E-47A37C99D706Q38723115-8E8C19F4-A091-4418-A431-53237A3A3527Q38824421-AD0BFEC5-AF58-4E83-8665-F021808A0731Q39148199-36A6F446-561E-4C6C-A949-53597AD5D491Q39720959-328B35FA-C155-4BCD-BB6E-99A1AD18BF78Q41994013-B1C2C20F-EEB2-4504-BBF1-C97070DCB082Q42059207-4E242397-F892-47C1-997C-F21E8C4399C7Q43751053-EFD4BD35-F641-4265-8928-270E9BA8E283Q45366387-8698FD10-38F7-4ECD-8DB1-18246F86C88B
P2860
Caveolae--an alternative endocytotic pathway for targeted drug delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Caveolae--an alternative endocytotic pathway for targeted drug delivery.
@ast
Caveolae--an alternative endocytotic pathway for targeted drug delivery.
@en
type
label
Caveolae--an alternative endocytotic pathway for targeted drug delivery.
@ast
Caveolae--an alternative endocytotic pathway for targeted drug delivery.
@en
prefLabel
Caveolae--an alternative endocytotic pathway for targeted drug delivery.
@ast
Caveolae--an alternative endocytotic pathway for targeted drug delivery.
@en
P1476
Caveolae--an alternative endocytotic pathway for targeted drug delivery
@en
P2093
Gyorgy Bathori
P356
10.1615/CRITREVTHERDRUGCARRIERSYST.V21.I2.10
P577
2004-01-01T00:00:00Z